Skip to main content
University of California San Francisco
UCSF  |  
About UCSF   |   Search UCSF
Home
Technology Disclosure
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding for Translational Technology
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Resources
    • Policies
    • Forms
    • Outgoing Material Transfer
    • Industry Statistics
    • Startup Resources
    • Translational Opportunities
    • Jobs & Internships
    • Partnering with Industry FAQs
    • Protecting Your Idea
    • Technology Disclosure
  • About
    • Events
    • Contact
    • Success Stories
    • Featured Startups
    • Teams
  • Media
    • News
    • Newsletters
    • Podcasts
    • Videos
  • linkedin
  • vimeo
  • youtube
Skip to main content
  • Home
  • Media

UCSF Innovation News

UCSF's latest innovations in healthcare & technology

NEWS


UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline
UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline 06/05/2019
Tumor Regression Discovery Gets FDA Green Light
Tumor Regression Discovery Gets FDA Green Light 05/16/2019
Tmunity and UCSF Announce Collaboration
Tmunity and UCSF Announce Collaboration 05/02/2019
One Day There May Be a Drug to Turbocharge the Brain. Who Should Get It?
One Day There May Be a Drug to Turbocharge the Brain. Who Should Get It? 04/03/2019
Fortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel Anti-CD46 Therapeutic for Treatment of Late-Stage Prostate Cancer and Multiple Myeloma
Fortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel Anti-CD46 Therapeutic for Treatment of Late-Stage Prostate Cancer and Multiple Myeloma 11/07/2018
Venn Acquires Cancer Immunotherapy Antibody
Venn Acquires Cancer Immunotherapy Antibody 04/23/2018
Roche Acquires Inception 5 Multiple Sclerosis (MS) Program Built on Discoveries by Dr. Jonah Chan at UCSF, Versant Forms New Company
Roche Acquires Inception 5 Multiple Sclerosis (MS) Program Built on Discoveries by Dr. Jonah Chan at UCSF, Versant Forms New Company 04/05/2018
Gilead Sciences and Kite to Acquire Cell Design Labs, One of UCSF Startups for $567 MM
Gilead Sciences and Kite to Acquire Cell Design Labs, One of UCSF Startups for $567 MM 12/07/2017
FDA Approves RxSight's Light Adjustable Lens, First IOL To Enable Refractive Correction After Cataract Surgery
FDA Approves RxSight's Light Adjustable Lens, First IOL To Enable Refractive Correction After Cataract Surgery 11/27/2017
Next-Gen Precision Diagnostics Now Available at UCSF
Next-Gen Precision Diagnostics Now Available at UCSF 08/28/2017
Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors
Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors 08/28/2017
New Vice Chancellor to Nurture Inventions, Bring Products to Market at More Advanced Stage
New Vice Chancellor to Nurture Inventions, Bring Products to Market at More Advanced Stage 04/25/2017
  • Previous page ‹‹ Prev
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • About
    • Events
    • Contact
    • Featured Startups
    • Success Stories
    • Teams
  • Teams
    • Engagement & Opportunity Development
    • Technology Licensing
    • Strategic Alliances
    • Business Affairs & Strategic Partnerships
    • Catalyst
  • Services
    • HealthTech Commercialization
    • Innovation & Entrepreneurship
    • Funding
    • Catalyst Program
  • Partnerships
    • Finding an Industry Partner
    • Establishing Research Collaborations
    • Panther Program
    • Precision Medicine
    • QB3
    • UCSF Health
  • Resources
    • Innovation Showcase
    • Translational Opportunities
    • Forms
    • Outgoing Material Transfer
    • Policies
    • Startup Resources
    • Partnering with Industry FAQs
    • Leadership Dashboard
    • Protecting Your Idea
    • Technology Disclosure

RECENT NEWS

  • United Therapeutics Corporation Acquires Thymmune Therapeutics
  • UCSF Innovation Translates Discovery into Life-Saving Diagnostics
  • Inventor of Crispr is skeptical about AI

Contact

  • Email:  [email protected]
  • UCSF Wayne and Gladys Valley Center
    490 Illinois Street, North Tower, 400-A
    San Francisco, CA 94143
  • Campus Mail: PO box: 2142
  • linkedin
  • vimeo
  • youtube
2026 ©  The Regents of the University of California
  • Accessibility
  • Usage
  • Privacy